Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015695
Filing Date
2025-06-04
Accepted
2025-06-04 20:32:00
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 form4-06052025_120657.html 4  
1 form4-06052025_120657.xml 4 4053
  Complete submission text file 0001415889-25-015695.txt   5568
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LOXO ONCOLOGY, INC. ONE LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address
Burstein Jennifer (Reporting) CIK: 0001640069 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 251024784